<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>South East European Journal of Cardiology Feed</title>
        <link>https://reference-global.com/journal/SEEJCA</link>
        <description>Reference Global RSS Feed for South East European Journal of Cardiology</description>
        <lastBuildDate>Tue, 17 Nov 2026 00:15:17 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>https://github.com/jpmonette/feed</generator>
        <image>
            <title>South East European Journal of Cardiology Feed</title>
            <url>https://paradigm-files.s3.eu-central-1.amazonaws.com/SEEJCA/cover-image.jpg</url>
            <link>https://reference-global.com/journal/SEEJCA</link>
        </image>
        <copyright>All rights reserved 2026, Sciendo</copyright>
        <atom:link href="https://reference-global.com/2/rss/journal/SEEJCA" rel="self" type="application/rss+xml"/>
        <item>
            <title><![CDATA[Successful Pregnancy with Uncorrected Tetralogy of Fallot: An Interdisciplinary Team Approach]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2024.6060</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2024.6060</guid>
            <pubDate>Tue, 12 Mar 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDWith an overall incidence of congenital cardiac disease, tetralogy of fallot (ToF) is the most clinical of cyanotic heart disease. The anomalies seen in patients with ToF are due to an inappropriate anterior and cephalad displacement of the interventricular septum’s infundibular (outflow tract) component. Ventricular septal defect, right ventricular hypertrophy, overriding aorta, and pulmonary stenosis are the four defects that result from this condition. The physiology of healthy women will undergo several changes affecting body system, including the cardiovascular system. Pregnancy and delivery have a high risk for most ill women, including those with uncorrected ToF, due to extensive physiological adaption and alterations. For patients with ToF, it continues to be a significant contributor to maternal morbidity (62.5%), mortality (10%), and neonatal adverse outcomes.CASE PRESENTATIONA 18-year-old female in her first pregnancy at 28 weeks was referred to Saiful Anwar Hospital with uncorrected ToF since she was 2 years old. She suggested repairing ToF at National Cardiovascular Center Harapan Kita Jakarta but her parents still refused. She married at 18 years old and she was pregnant unplanned before. Then, she was referred to RSSA for further management.CONCLUSSIONPregnancy has been related with higher risks of morbidity and mortality for women with congenital cardiac disease. ToF is the most prevalent cyanosis congenital heart disease. These are poorly tolerated and produce serious complications, including maternal and neonatal mortality. Prenatal counseling is crucial to identify risk factors for the patients and to reassure many patients who are at low risk.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Myocardial Infarction in Pregnancy: What Should We Do?]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2024.6067</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2024.6067</guid>
            <pubDate>Tue, 12 Mar 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[Acute myocard infarct during pregnancy is a rare event with high mortality and women with cardiac comorbid such as hypercholesterolemia, hypertension, and history of myocardial infarction are one of risk that should be warning. However, the main etiology myocard infarct in pregnancy is spontaneous coronary artery dissection, especially in the third semester. Women with unusual chest pain, ST-elevation in electrocardiogram, and sudden cardiac arrest should treat as soon as possible. Patient with unstable condition revascularization is recommended. However, there are several things that should be monitor during revascularization such as consideration type of stent, how much contrast that will be use, and planning after stent implantation. Thrombolysis should be the last option because of bleeding risk. Therapy during and after pregnancy should be monitor continuously because of their side effect to mother and baby, and delivery in women with acute myocard infarct should be one of main concerns. With this review, we hope that we can raise our awareness in pregnant women with their comorbid and their future pregnancy.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Inherited Stanford A DeBakey I Aortic Dissection: Unveiling Genetic Predispositions and Surgical Management]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2024.6066</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2024.6066</guid>
            <pubDate>Tue, 12 Mar 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDAortic dissection refers to the disruption of the medial layer of the aorta caused by intramural hemorrhage. This leads to the separation of the layers of the aortic wall, resulting in the establishment of a true lumen and a false lumen, which may or may not be connected. The prevalence of aortic dissection ranges from 0.2% to 0.8%. Additionally, a notable percentage, surpassing 20%, of individuals exhibit a familial inclination towards thoracic aorta dissection.CASE PRESENTATIONA male patient in his middle age, 41 years old, with risk factors of uncontrolled hypertension, obesity, and a familial propensity to aortic dissection, presented to the emergency department exhibiting symptoms of chest pain. It characterized the sensation as having a tearing quality and indicated that it extended towards the abdomen region. The results of the test revealed several notable findings. A blood pressure reading of 235/133, a wider mediastinum and cardiomegaly on the chest X-ray, a slight increase in Hs-Troponin levels, and an electrocardiogram showed sinus rhythm with left ventricular hypertrophy. He underwent a computed tomography scan, which revealed the existence of an aortic dissection that extended from the ascending to the descending aorta without any aortic valve involvement. He was assessed with a Stanford A. DeBakey I aortic dissection, and underwent successful therapy for aortic arch replacement with the elephant trunk procedure, and plans to undertake an endovascular procedure for the descending aorta in the upcoming period.CONCLUSIONAortic dissection is a pathological disorder that may exhibit hereditary inheritance, and the choice of surgical technique is dependent on the specific underlying disease.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Greater Saphenous Vein Aneurysm: Case Report]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6039</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6039</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDVenous aneurysms are rare vascular pathology. They were first described by Sir Wiliam Osler in 1915 and thereafter Harris in 1928. Aneurysm on greater saphenous vein is mostly asymptomatic or they are responsible for no more than local discomfort, pain, and tenderness and it is detected when patients were referred for the treatment or evaluation of a femoral or inguinal hernia or soft-tissue masses.CASE PRESENTATIONWe presented a case of a 64-year-old man admitted to the hospital for elective surgical treatment of greater saphenous vein aneurysm. Computed tomography angiography showed an aneurysmatic change on the saphenous vein on the right lower leg with dimension of aneurismae 41 × 40 × 39 mm. After the diagnostic examination was finish, there was an indication for surgical treatment. The patient was successfully operated with non-postoperative complications.CONCLUSIONThe indications for surgical treatment in superficial venous aneurysms are the presence of symptoms, the risk of thrombosis, compression of nearby structures, and more commonly esthetic problems. Surgical treatment is the treatment of choice for reducing the symptoms, risk of thrombosis, and esthetic problems and it has excellent results if there are not any other vascular pathologies.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Management Heart Failure with Preserved Ejection Fraction: A Mini Review]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6051</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6051</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDHeart failure (HF) is a complex clinical syndrome that results when heart’s ability to contract or fill is impaired structurally or functionally. Current guideline has been classified HF according to level of left ventricular ejection fraction (EF). 1) Heart failure with reduced ejection fraction (HRrEF): EF ≤ 40%; 2) Heart failure with mildy ejection fraction (HRmrEF): EF 41 - 49%; 3) Heart failure with preserved ejection fraction (HRpEF): EF ≥50%.AIMWe aimed to analyse the management of heart failure with preserved ejection fraction.METHODSWe conducted a literature search of relevant articles in various databases (Pubmed &amp; Google Scholar). Articles to include in the review was based on agreement of the authors.RESULTSHeart failure with preserved ejection fraction (HFpEF) accounts for 50% of all heart failure cases. HFpEF remains a challenging condition to diagnose given its unclear and often heterogenous etiology with numerous clinical mimics and complex systemic pathophysiology.CONCLUSIONAdditionally, effective treatment modalities are limited with numerous negative clinical trials over the past few decades. In this review, we updated the last knowledge of management HFpEF by reviewing recent guideline and studies.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[The Role of Microtubules in Heart Failure]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6045</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6045</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[Heart failure (HF) is a complex pathological state in which cardiac performance fails to match perfusion demand, commonly preceded by an enlargement of the heart known as cardiac hypertrophy. Pathological changes in the microtubule network (MTN) organization have been shown to increase cellular stiffness and lead to contractile dysfunction of cardiomyocytes. In this narrative review, we are focusing on the role of the microtubule and also its mechanism in the heart, especially in HF. We conducted literature research for published articles carried out from 2012 to 2022. Microtubules are polymers that serve as structural elements with the shape of long, rigid tubes that are highly dynamic. The stiffness of the myocardium is largely influenced by the MTN. Through various methods, the MTN is remodeled during cardiac hypertrophy and HF. Targeting microtubules for the treatment of HF might become a new approach to improve the outcome. While colchicine inhibits various microtubule-dependent cellular in interphase cells and proliferation, it needs further study for the safety of the adjusted dosage. Manipulating detyrosination of microtubules might be useful for restoring the function of failing myocytes although there are still very limited data on this.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Early Identification and Early Intervention for Better Result Transluminal Angioplasty in Hemodialysis Patient]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6062</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6062</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDStasis, thrombosis, and impaired arteriovenous (AV) fistula are possible problems to manifest central venous stenosis (CVS). Almost 25% dysfunctional fistulas at patient with dialysis are known to have these problems. Proper and immediate identification of CVS is critical to improve the successful rate of percutaneous transluminal angioplasty (PTA) in hemodialysis patient. We present the immediate decision of CVS in hemodialysis patients.CASE PRESENTATIONThis is case of a 53-year-old woman complaining of left arm swelling for 2 weeks. These complaints are not combined by pain, fever, or accidental injuries to the arm. She routinely undergoes hemodialysis (HD) twice a week with AV fistula access in the left arm for 12 years. HD can still run smoothly even with swelling in her left arm. PTA was performed without waiting HD problem as an immediate management of CVS and resulting without any complications.CONCLUSIONCVS is generally associated with long-term AV fistula. The endothelial injury from physical stimulation of the vein wall preceded the development of CVS and also developed smooth muscle proliferation and microthrombi. PTA as an immediate procedure for CVS has high rate of success although patentability is low in long-term condition. This patient is still needed to follow-up for determining long-term patency.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Speckle Tracking Analysis of Mitral Annular Calcification and Left Ventricular Mechanics]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6059</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6059</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDClinical echocardiography often reveals mitral annular calcification (MAC), and this condition has been connected to atherosclerosis and cardiovascular risk factors. To this day, our knowledge of the left ventricle’s (LV) physiology is still somewhat restricted. Using 2D speckle tracking echocardiography, we analyzed the connection between MAC and LV mechanical functions (2DSTE).AIMThe purpose of the current investigation is to assess how left ventricular mechanics are impacted by MAC.MATERIALS AND METHODSBetween April 2020 and October 2021, this prospective and cross-sectional study was carried out in Islamic Center of Cardiology Al Azhar University and Cardiology Department of Al Hussien University Hospital. Eighty participants were utilized in the study. When necessary, patients were referred to the Cardiology Clinics at the Medical Schools of Al Azhar University for follow-up care. Sixty MAC patients were studied with 20 healthy controls of similar age and gender. All patients had a 2D echocardiogram. Sixty consecutive patients with a MAC diagnosis and 20 age-and sex-matched controls with normal cardiac evaluations made up the study population. The patients were all given a 2D echocardiogram.RESULTSThe longitudinal strain significantly decreased as the MAC severity rose. The LV’s rotating mechanics varied greatly among MAC organizations. The E/A ratio, the global longitudinal speed (GLS), and the systolic tissue velocity were all shown to have a negative correlation with MAC thickness. Additional variables were found to have statistically significant connections. There were significant correlations between MAC severity and age, LV mass index, and t-LV UR. Age, LV mass index, and linear speed were significantly related to MAC severity.CONCLUSIONThe LV ability to contract systolically and diastolically is compromised when MAC is both present and severe. The LV ability to contract systolically and diastolically is likewise impacted by an increase in MAC severity.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Fulminant Myocarditis Mimicking Myocardial Infarction in a Young Woman: A Challenging Diagnosis and Treatment]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6065</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6065</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDFulminant myocarditis is a rare and serious condition with high mortality. It poses diagnostic challenges due to myocardial infarction-like symptoms and rapid deterioration. Timely diagnosis and access to advanced interventions are vital for optimal management and improved outcomes.CASE PRESENTATIONA 34-year-old woman presented with typical chest pain, ST changes, positive cardiac biomarkers, and impaired left ventricle function. The presumptive diagnosis was fulminant myocarditis complicated with cardiogenic shock, respiratory failure, and acute kidney injury. Leukocytosis and high anti-streptolysin O (ASO) titer suggested a recent streptococcal infection as a possible cause. Advanced intervention limitations hindered patient management. On the second day, the patient had a cardiac arrest.CONCLUSIONThe diagnosis can be challenging due to the similarity of symptoms and signs to myocardial infarction, combined with the rapid deterioration of the patient’s condition. Prompt initiation of mechanical circulatory support is vital. However, its limited availability in developing countries hinders routine implementation, leading to unfavorable outcomes when life support measures are unavailable.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[A Curious Case of Acute STEMI in a Young Patient; Things are Not Always What They Seem]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6047</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6047</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDAcute myocardial infarction (MI) is a rare occurrence in patients under 40 years of age without positive family history for coronary artery disease (CAD). Genetic conditions as inherited thrombophilia can lead to a hypercoagulable state, resulting in thromboembolic events and arterial thrombosis.CASE SUMMARYWe present a case of a 35-year-old male patient who presented to the emergency room with an inferior MI after a strenuous cycling exercise. An urgent coronary angiography showed thrombotic formations in the right coronary artery without atherosclerotic plaques. Plain old balloon angioplasty and thrombus aspiration were performed, which was followed by GP IIb/IIIa inhibitor infusion and unfractionated heparin for 24 h. From past medical history, the patient had COVID-19 like symptoms 20 days before the event and had his first dose of anti-COVID vaccine 2 weeks prior. After additional testing, molecular genetic analysis results revealed the patient to be heterozygous for factor V Leiden (FVL) and homozygous for methylenetetrahydrofolate reductase C677T gene mutation. The patient was discharged on direct oral anticoagulant and antiplatelet therapy. After 1-year follow-up, he had no symptoms or recurrent cardiovascular events.CONCLUSIONInherited thrombophilia is а significant risk factor for CAD and performing genetic testing in younger patients with a cardiovascular event and plays an important role for adequate treatment and prophylaxis from recurrent complications. The use of oral anticoagulation for prophylaxis is shown to be effective in these patients. However, further studies are needed to prove their exact role and duration of treatment.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Early Coronary Artery Disease in a Female Patient with Discoid Lupus Erythematosus and Hashimoto’s Thyroiditis]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6048</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6048</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDAtherosclerosis is a chronic inflammatory condition involving the endothelium of the blood vessels, predominant the coronary arteries. Main risk factors are dyslipidemia, hypertension, diabetes, smoking, obesity, and lack of physical activity. Patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis etc., have a twofold increased risk of developing CAD at younger age, compared with the general population.CASE REPORTA 41-year-old female patient, with history of smoking and dyslipidemia, was admitted to our hospital with acute inferoposterior myocardial infarction. Initially, coronary reperfusion therapy per protocol was administrated and primary percutaneous coronary intervention (PCI) was performed. Multivessel CAD was found, and two stents were implanted on obtuse marginal and circumflex artery. Transthoracic echocardiography (TTE) revealed left ventricle systolic and diastolic dysfunction with segmental hypokinesis. Additionally, the patient was first diagnosed with DLE at the age of 15, but the disease was uncontrolled in the last 7 years. She also has hypothyroidism, regularly treated with hormone replacement therapy. The patient was discharged with medicamentous therapy including dual antiplatelet agents, statin, beta-blocker, angiotensin-receptor blocker, potassium sparing diuretic and proton pump inhibitor. One month later, recoronarography was performed with stenting of left anterior descending artery. TTE showed improvement of the left ventricle systolic function with preserved ejection fraction. The blood test showed elevated levels of antithyroid antibodies. A rheumatologist was consulted, who recommended therapy with hydroxychloroquine and regular follow-ups.CONCLUSIONIn younger patients with chronic inflammatory diseases, inflammatory mediators play a significant role in the development of the atherosclerotic plaques, regardless of co-existing risk factors. Therefore, an early cardiovascular assessment is required in these patients for preventing severe or life-threatening cardiovascular events.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Management of Refractory Central Vein Stenosis in Hemodialysis Patient]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6055</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6055</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDPatient with hemodialysis (HD) is prone to central venous stenosis (CVS). The presence of CVS contributed to poor dialysis adequacy. Symptomatic CVS is treated with percutaneous transluminal angioplasty (PTA) with or without a stent. This report aimed to understand the characteristics of PTA with or without a stent.CASE PRESENTATIONA 43-year-old woman was admitted to the hospital with a chief complaint of a deteriorating swollen right arm with pain 1 week prior. Patient had been on HD since 2019, had AV shunt access, continuous ambulatory peritoneal dialysis (CAPD), and 4 times balloon angioplasty due to similar complaints. Diagnoses of the patient were AV shunt stenosis, chronic kidney disease Stage 5 on CAPD, heart failure Stage C FC II, hypertension on treatment, anemia related to renal disease, and severe hypoalbuminemia based on anamnesis and extensive examination. PTA with stent was conducted in this patient and showed TIMI Flow III.CONCLUSIONPTA is the primary treatment for symptomatic CVS. A stent implantation is used in cases that failed PTA treatment. PTA with a stent provides immediate symptom alleviation and benefits an angioplasty-resistant lesion by secondary patency.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Pulmonary Thromboembolism in a Patient Suspected for Myocarditis - Case Report]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6046</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6046</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDThe following case presentation highlights the diagnostic and therapeutic approach to a patient with a rare disease.CASE PRESENTATIONA 47-year-old man was hospitalized with chest pain, shortness of breath, and fatigue. Initial blood test analysis revealed elevated CRP, leukocytosis, and elevated cTn-I. Due to suspected myocarditis, cardiac magnetic resonance (CMR) imaging was performed. CMR ruled out myocarditis. In addition, there were no signs of edema or late gadolinium enhancement (LGE). However, there was evidence of enlarged right ventricular heart chambers. Cine short-axis images and LGE sequences revealed masses in the pulmonary artery, highly suspicious of thrombi. D-dimer was analyzed, showing very high values, and additionally, CTPA confirmed the diagnosis of pulmonary embolism (PE). Venous Doppler ultrasonography demonstrated DVT in the right popliteal vein. Anticoagulation with LMWH was initiated, after which a drug from the NOAC class - Rivaroxaban was given according to a PE protocol. The patient was discharged from the hospital in a hemodynamically stable condition with a recommendation to adhere to the therapy and conduct control after 1 and 3 months of hospitalization.CONCLUSIONThanks to multimodality imaging, we find it easier to get the specific cause of the problem, by establishing it or by ruling it out. However, the most important thing is to have a high clinical suspicion and common sense for faster diagnosis, treatment, and early recovery of the patient.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Effectiveness of Health Management Education for Congestive Heart Failure Patients in Surabaya]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6041</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6041</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDHealth problems with cardiovascular system disorders including congestive heart failure (CHF) still rank highly. CHF is one of the heart diseases that continue to increase in incidence and prevalence every year, including in Indonesia. Lack of health education about how home care is a factor increases the incidence of rehospitalization in CHF patients. Here, researchers have provided knowledge to patients about how things to avoid, foods to avoid, recommended foods, and diet to do.OBJECTIVEThis study aimed to analyze effectiveness of health management education for CHF patients in Surabaya.METHODSThe research method used is quantitative analytics with a pre-experimental design with an approach (one group pre-post-test design). The population in this study was all CHF patients admitted to hospitals in Surabaya as many as 150 respondents. Sampling using accidental sampling technique. Data were analyzed using and Wilcoxon test.RESULTSWilcoxon test results obtained knowledge (p = 0.000), diet (p = 0.001), and physical activity (p = 0.001) which means there is an influence on providing health management education for CHF patients.CONCLUSIONHealth management education effectiveness for CHF patients in Surabaya. Health-care providers can add health education programs for patients with CHF or other diseases, as a form of nursing service implementation.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Artificial Intelligence Enhances Heart Surgeries]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6056</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6056</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDHeart surgery is used to treat serious heart diseases.METHODSThis is a perspective article on heart surgeries, by reviewing the papers on Europe percutaneous mitral commissurotomy (PMC) concerning heart surgeries, as Europe PMC is a trusted academic engine. The author included all papers on the subject, but papers from the last 5 years are the favorite for references, without exclusion from review.RESULTSThere are 192,265 case reports (28.5%), 143,267 clinical trials (21.2%), 303,690 reviews (45%), and 34,323 miscellaneous (5%).CONCLUSIONSArtificial intelligence is the future of advances in heart surgeries as they are highly distributed in the world.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Isolated Right Ventricular Infarction without Right Ventricular Dysfunction: A Case Report]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6052</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6052</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDMyocardial infarction is the leading cause of the occlusion of the coronary artery. Meanwhile, right ventricular myocardial infarction (RVMI) is usually associated with inferior left ventricular infarction in 10–50% of cases. We presented isolated RV infarcts which are rare cases that happen in only 3% of total myocardial infarction.CASE PRESENTATIONWe presented a case of a 67-year-old man with sudden chest pain, shortness of breath, and a history of diabetes mellitus. From his 12 lead electrocardiogram, there is no specific ST elevation yet elevation in V3R and V4R and elevated troponin I highly sensitive value. The patient developed junctional bradycardia and early percutaneous coronary intervention backup temporary pacemaker showed total occlusion in the proximal right coronary artery (RCA)CONCLUSIONThe RVMI commonly occurs in the dominant RCA that also supplies the sinoatrial node and atrioventricular node. Therefore, due to its location that passed through the RCA, bradycardia to complete heart block may happen. Isolated right ventricular (RV) infarction may happen because either RV marginal as the predominant location is occluded, or non-dominant RCA occluded by thrombus. RV infarction may impair RV contractility causing a decrease in RV stroke volume and this condition leads to hypotension, shock, and severe hemodynamic derangement. Meanwhile, acute proximal RCA occlusions do not result in significant RV necrosis, one of the reasons is collateral flow from the left coronary system further protects from RV dysfunctions in our patient.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Interatrial Septum Hypertrophy: A Pitfall in Bicaval Cannulation]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6044</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6044</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDLipomatous hypertrophy of the interatrial septum is a rare benign cardiac condition characterized by fatty tissue infiltration of the septum.CASE PRESENTATIONWe presented some interesting images and some possible pitfalls during the cannulation in this circumstance.CONCLUSIONSurgical therapy appears to be reserved to patients with SVC obstruction or any rhythm disturbances.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Characteristics, Clinical Manifestations, Length of Hospitalization, and Nutritional Status of COVID-19 Patients]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6040</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6040</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDThe disease that is endemic and has become a global pandemic is COVID-19 due to reports of thousands of cases. The pandemic is weighing on intensive care units with an influx of COVID-19 patients. The clinical manifestations of COVID-19 vary, diagnostic examinations and treatment are also experiencing dynamic developments. This study aims to provide an overview of the characteristics, clinical manifestations, length of treatment, and nutritional status of COVID-19 patients.METHODSThis study used a descriptive analytic cross-sectional method with inclusion criteria that were positive for COVID-19. The research data were obtained from 130 hospital medical records for the period June to August 2021. The collected data were then analyzed using SPSS.RESULTSThe study found that men were more exposed to COVID-19 (71.5%) and 70% of patients worked as medical personnel. The age range of the majority of patients was more than 40 years (78.5%). Most of the comorbidities were hypertensive patients. Clinical manifestations of COVID-19 patients were cough (44.6%), fever (40%), flu-like symptoms (32.3%), painful swallowing (26.2%), anosmia (16.2%), shortness of breath (15.4%), nausea (14.6%), vomiting (13.8%), and diarrhea (0.9%). The average length of stay is 7–14 days (9.2%) with adequate nutritional status (14.6%). Patients with length of treatment (p = 0.01) and poor nutritional status (p = 0.000) were significantly different.CONCLUSIONThe majority of COVID-19 sufferers are male, over 40 years old, with cough symptoms, and the most comorbid hypertension, as well as deaths from hypertension and the elderly. Better treatment is needed for people with COVID-19.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Complex Combination of Pulmonary Embolism, Stroke, and ST-Segment Elevation Myocardial Infarction in Young Patient with Recent COVID-19 Infection and Newly Diagnosed Lung Carcinoma]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6053</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6053</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDIschemic stroke, pulmonary embolism (PE), and acute ST-segment elevation myocardial infarction (STEMI) are very rarely all present in younger patients without classical risk factors or a family history of dyslipidemia or cardiovascular disease. They represent a medical emergency and necessitate fast diagnosis, treatment, and search for etiology, not explained purely by atherosclerosis. Thrombophilia testing should be considered in younger patients with several major thrombotic episodes, although there is much disagreement concerning the importance of homocysteine level testing in patients with arterial and venous thrombotic events, including PE. COVID-19 infection may trigger several thrombotic complications caused by unique immunothrombotic processes.CASE PRESENTATIONA 44-year-old patient complaining of chest pain was admitted at our clinic due to acute anterior STEMI. He has a previous medical history of ischemic stroke, COVID-19 infection, and PE in the past 2 months. Newly, diagnosed lung adenocarcinoma was confirmed by biopsy 10 days before STEMI admission, without surgical or previous hemotherapy. The patient was on regular anticoagulant therapy with rivaroxaban 20 mg OAD and antiplatelet therapy with Aspirin due to previous PE and ischemic stroke. Patient denied standard risk factors, family history for cardiovascular disease or any previous minor or major bleedings, history of anemia, liver, or renal dysfunction. Acute stroke was confirmed by brain computed tomography imaging. Thrombophilia panel testing revealed homozygote mutations for MTHFR 677 gene, heterozygote mutation for integrin subunit alpha 2, and fibrinogen B beta chain) genes. The patient was treated with low molecular weight heparin, aspirin, clopidogrel, and heart failure therapy in the acute phase. Clinical consultations were performed with a team of doctors which included a cardiologist, neurologist, and oncologist. Patients have a high bleeding risk, assessed by HAS-BLEED score of 4.CONCLUSIONOur patient is a rare case of serious multi-vascular thrombotic events with underlying thrombophilia, lung cancer, and past COVID-19 infection complicated by pulmonary embolism, ischemic stroke, and STEMI.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Severe Mitral Valve Dysfunction: A Giant Left Atrial Myxoma Was the Guilty]]></title>
            <link>https://reference-global.com/article/10.3889/seejca.2023.6054</link>
            <guid isPermaLink="false">/article/10.3889/seejca.2023.6054</guid>
            <pubDate>Mon, 25 Dec 2023 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDLeft atrial (LA) myxoma’s clinical manifestation depends on the size, location, mobility, and architecture of the tumor. The clinical presentation consists of cardiac (67%), embolic (29%), and systemic (34%) symptoms, even sudden cardiac death.CASE PRESENTATIONWe present an interesting case and images of a patient with severe mitral valve dysfunction and syncope, who was diagnosed with a giant mass in the left atrium and left ventricle as myxomas. Open heart surgery was performed and the mass was detected and successfully removed. The histopathology confirmed the diagnosis of myxoma of the left atrium.CONCLUSIONMyxoma may be challenging to diagnose, but with imaging techniques, such as transthoracic (TTE), transesophageal (TEE) echocardiograms, when a high index of clinical suspicion exists, early diagnosis and therefore curative intervention in the majority of the cases is more likely.]]></description>
            <category>ARTICLE</category>
        </item>
    </channel>
</rss>